Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 1/20 | 0.51 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 6/20 | 0.40 |
| ▸ | RAB9A | P51151 | 6/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | DGAT1 | O75907 | 2/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | DHFR | P00374 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.37 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1899350 | 0.87 | S1PR1 (0.63) | S1PR1TRPV1ALDH1A1HSD17B10NPC1 | |
| SCHEMBL29142401 | 0.80 | S1PR1 (0.64) | S1PR1TRPV1ALDH1A1HSD17B10NPC1 | |
| SCHEMBL11667207 | 0.77 | TRPA1 (0.46) | S1PR1ALDH1A1NPC1RAB9ATP53 | |
| SCHEMBL22567795 | 0.76 | S1PR1 (0.48) | S1PR1ALDH1A1HSD17B10NPC1RAB9A | |
| SCHEMBL27736916 | 0.75 | NPC1 (0.46) | ALDH1A1NPC1RAB9AL3MBTL1PLA2G1B | |
| SCHEMBL3398445 | 0.75 | ALDH1A1 (0.52) | S1PR1TRPV1ALDH1A1HSD17B10NPC1 | |
| SCHEMBL23610039 | 0.74 | ALDH1A1 (0.50) | S1PR1TRPV1ALDH1A1HSD17B10NPC1 | |
| SCHEMBL5552881 | 0.74 | ALDH1A1 (0.48) | ALDH1A1HSD17B10NPC1RAB9AL3MBTL1 | |
| Hydrazine SCHEMBL1780923 | 0.73 | TRPA1 (0.38) | ALDH1A1HSD17B10LMNASMN1; SMN2TRPA1 | |
| Ammonia Solution, Strong SCHEMBL4590379 | 0.73 | TRPA1 (0.40) | ALDH1A1HSD17B10LMNASMN1; SMN2TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12588354-B2 | Light-emitting device including fused cyclic compound, electronic apparatus including the light-emitting device, and the fused cyclic compound | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-03-24 | — | — | US | disclosed |
| US-20220278295-A1 | LIGHT-EMITTING DEVICE INCLUDING FUSED CYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE FUSED CYCLIC COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12588354-B2 | Light-emitting device including fused cyclic compound, electronic apparatus including the light-emitting device, and the fused cyclic compound | CRY1, SCO2, RER1 | S1PR1 3613/4885TRPV1 2458/4885ALDH1A1 1115/4885 |
| US-20220278295-A1 | LIGHT-EMITTING DEVICE INCLUDING FUSED CYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE FUSED CYCLIC COMPOUND | CRY1, LEF1, LAGE3 | S1PR1 4798/4885TRPV1 1991/4885ALDH1A1 86/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.